Table 3 Hazard ratios of diabetes incidence comparing individual angiotensin receptor blocker with losartan
| Â | Valsartan | Irbesartan | Candesartan | Telmisartan | Olmesartan |
|---|---|---|---|---|---|
All subjects | |||||
Crude | 0.99 (0.97-1.01) | 0.95 (0.93-0.97) | 1.13 (1.09-1.17) | 0.98 (0.95-1.01) | 1.35 (1.29-1.40) |
Multivariable regression analysis | 1.01 (0.99-1.03) | 0.99 (0.97-1.02) | 0.99 (0.96-1.03) | 0.99 (0.96-1.03) | 1.07 (1.03-1.12) |
Multivariable regression adjusted for mean daily dosage | 1.01 (0.99-1.03) | 0.99 (0.97-1.01) | 0.99 (0.96-1.02) | 0.99 (0.96-1.02) | 1.07 (1.03-1.12) |
Excluding those followed for less than one year | |||||
Crude | 1.00 (0.98-1.02) | 0.97 (0.94-0.99) | 1.18 (1.14-1.23) | 1.00 (0.96-1.03) | 1.48 (1.41-1.55) |
Multivariable regression analysis | 1.02 (1.00-1.04) | 1.01 (0.98-1.03) | 1.00 (0.96-1.04) | 1.00 (0.96-1.03) | 1.09 (1.04-1.14) |
Multivariable regression adjusted for mean daily dosage | 1.02 (1.00-1.04) | 1.00 (0.98-1.03) | 0.99 (0.96-1.03) | 1.00 (0.96-1.03) | 1.09 (1.05-1.14) |